Adding methotrexate to etanercept versus etanercept monotherapy in adults with moderate to severe plaque psoriasis: Efficacy and safety

被引：0
|
作者：
Gottlieb, Alice B. [1 ]
Strober, Bruce E. [2 ]
Kricorian, Gregory [3 ]
Langley, Richard G. [4 ]
机构：
[1] Tufts Med Ctr, Boston, MA USA
[2] NYU, Sch Med, New York, NY USA
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
[4] Dalhousie Univ, Halifax, NS, Canada
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2012年 / 66卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB184 / AB184
页数：1
相关论文
共 50 条
  • [41] Safety and efficacy of HCV eradication during etanercept treatment for severe psoriasis
    Pescitelli, Leonardo
    Lazzeri, Linda
    Tripo, Lara
    Ricceri, Federica
    Di Cesare, Antonella
    Prignano, Francesca
    [J]. DERMATOLOGIC THERAPY, 2018, 31 (04)
  • [42] Treating severe plaque psoriasis in a paediatric patient with etanercept
    Stevenson, P.
    Sander, C.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2017, 58 : 88 - 88
  • [43] Efficacy of etanercept in combination with methotrexate in moderate-to-severe rheumatoid arthritis is not dependent on methotrexate dosage
    Gallo, G.
    Brock, F.
    Kerkmann, U.
    Kola, B.
    Huizinga, T. W. J.
    [J]. RMD OPEN, 2016, 2 (01):
  • [44] The ACCEPT study: ustekinumab versus etanercept in moderate-to-severe psoriasis patients
    Young, Melodie S.
    Horn, Elizabeth J.
    Cather, Jennifer C.
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (01) : 9 - 13
  • [45] Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study
    van Riel, P. L. C. M.
    Taggart, A. J.
    Sany, J.
    Gaubitz, M.
    Nab, H. W.
    Pedersen, R.
    Freundlich, B.
    MacPeek, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (11) : 1478 - 1483
  • [46] Study Completion and Etanercept Retention in Patients with Rheumatoid Arthritis Treated with Etanercept Monotherapy Versus Etanercept and Methotrexate Combination Therapy
    Pope, Janet E.
    Keystone, Edward C.
    Thorne, J. Carter
    Poulin-Costello, Melanie
    Phan-Chronis, Krystene
    Haraoui, Boulos
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [47] Efficacy and safety of secukinumab in moderate to severe plaque psoriasis
    Aparicio Rubio, Celia
    Monteagudo Santolaya, Emilio
    Cornejo Uixeda, Silvia
    Prieto Castello, Manuel
    Antonino de la Camara, Gonzalo
    Quintana Vergara, Belen
    Sanchez Alcaraz, Agustin
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 299 - 299
  • [48] Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis
    Strober, B. E.
    Crowley, J. J.
    Yamauchi, P. S.
    Olds, M.
    Williams, D. A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (03) : 661 - 668
  • [49] Efficacy of etanercept in the management of plaque psoriasis and psoriatic arthritis
    Poulin, Yves
    Gupta, Aditya K.
    Amiss, John D.
    [J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2007, 11 : S14 - S22
  • [50] Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
    Griffiths, Christopher E. M.
    Strober, Bruce E.
    van de Kerkhof, Peter
    Ho, Vincent
    Fidelus-Gort, Roseanne
    Yeilding, Newman
    Guzzo, Cynthia
    Xia, Yichuan
    Zhou, Bei
    Li, Shu
    Dooley, Lisa T.
    Goldstein, Neil H.
    Menter, Alan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (02): : 118 - 128
12345